Enzyme-Support Interactions of Burkholderia cepacia Lipase Immobilized on Silica Using Molecular Docking and Multitechnique Characterization
Abstract
The influence of the microenvironment within enzyme-support complexes on the activity of Burkholderia cepacia lipase (BCL) immobilized on silica (SiO2-BCL) remains insufficiently understood. Without data on these interactions, it is challenging to determine whether modifications to the support material or immobilization protocols are needed for optimal enzyme activity and stability. Besides evaluating catalytic performance in esterification reactions, enzyme-support interactions were characterized using 29Si NMR, FTIR, BET, DSC, TGA, SEM-EDS, and molecular docking simulations. In this study, NMR29Si-based structural analysis revealed significant protein-surface (pore wall) interaction networks. The immobilization resulted in 88.6% efficiency and a protein loading of 17.72 mg·g-1, enabling further structural and functional characterization. Molecular docking elucidated the interaction mechanisms between silica functional groups (Qn sites) and BCL binding residues. Docking simulations indicated that the Q3 group interacts with the catalytic residue Ser87, potentially hindering substrate access to the active site. Spectroscopic and morphological analyses confirmed this interaction and correlated it with a significant decrease in enzymatic activity. Experimental evidence and FTIR analyses demonstrated that the increase in the α-helix content of SiO2-BCL correlated with the observed decrease in catalytic productivity. BCL exhibited a significantly higher esterification…
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.